Chemotherapy for Breast Cancer in India: Cost, Cycles and Side Effects

Chemotherapy is one of the systemic treatments used to treat breast cancer. It uses medicines that travel through the bloodstream to destroy or control cancer cells. This guide supports the Breast Cancer Treatment in India pathway and the cost guide.

Chemotherapy uses medicines that target rapidly dividing cells. Because chemotherapy medicines circulate throughout the body, they can treat cancer cells that may have moved away from the original breast tumour but are not yet detectable on imaging.

This is different from surgery and radiation therapy, which primarily treat specific areas of the body. Chemotherapy can therefore form part of a multimodal breast cancer treatment plan.

Depending on the situation, a patient may receive chemotherapy → surgery → radiation, or surgery → chemotherapy → radiation, or another sequence determined by the oncology team. Medical oncology teams in Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad decide the sequence from the type and stage of breast cancer.

No. Chemotherapy is not automatically required simply because someone has been diagnosed with breast cancer.

Doctors consider cancer stage, tumour size, lymph-node involvement, tumour grade, ER, PR and HER2 status, breast cancer subtype, age and menopausal status, overall health, previous treatment, response to treatment, and certain genomic or molecular test results in selected patients.

The purpose is to determine whether chemotherapy is likely to provide enough benefit to justify its potential risks and side effects. For some hormone-receptor-positive early breast cancers, additional genomic testing may help inform the chemotherapy decision in appropriate patients.

Chemotherapy given before surgery is called neoadjuvant chemotherapy. The treatment may be used to reduce tumour size, make surgery easier or possible, treat microscopic cancer cells throughout the body, assess how the cancer responds to treatment, and help guide subsequent treatment.

Neoadjuvant treatment is particularly relevant in some larger or locally advanced breast cancers and in selected HER2-positive and triple-negative cancers. Depending on the cancer subtype, neoadjuvant treatment may include chemotherapy combined with targeted therapy or immunotherapy.

Chemotherapy given after surgery is called adjuvant chemotherapy. The objective is to treat cancer cells that may remain elsewhere in the body even when the visible tumour has been removed after lumpectomy or mastectomy.

The need for adjuvant chemotherapy depends on the patient's risk profile and tumour biology. It is not automatically recommended after every breast cancer operation.

In Stage 4 breast cancer, chemotherapy may be used when systemic treatment is appropriate. The treatment goal is generally different from treatment of early-stage disease.

For metastatic breast cancer, treatment may aim to control the cancer, reduce symptoms, slow disease progression, maintain quality of life and extend survival. The choice between chemotherapy, hormone therapy, targeted therapy and other systemic treatments depends strongly on the cancer subtype.

One of the most important aspects of breast cancer treatment is that different biological subtypes can respond differently to systemic therapies.

If a breast cancer is ER-positive and/or PR-positive, hormone therapy can play an important role. Chemotherapy may or may not be required. The decision depends on the overall risk and characteristics of the cancer.

HER2-positive breast cancers can be treated with HER2-directed therapies. Chemotherapy may be combined with HER2-targeted treatment in appropriate patients. The exact combination depends on the stage and treatment setting.

Triple-negative breast cancer does not have significant expression of ER, PR or HER2. Chemotherapy is an important component of treatment for many patients with triple-negative disease. In selected situations, immunotherapy may also form part of treatment.

There is no universal number of chemotherapy cycles for breast cancer. The number depends on the type of breast cancer, stage, treatment objective, selected chemotherapy regimen, whether chemotherapy is being given before or after surgery, whether other systemic treatments are being used, patient response and tolerance of treatment.

Some regimens involve a small number of cycles, while others involve a longer course. The oncologist should provide a treatment schedule explaining medicine names, dose, frequency, number of cycles, expected duration, blood tests required and supportive medicines.

Patients should not compare their number of cycles directly with another patient's treatment because the underlying cancers and treatment regimens may be different.

A chemotherapy cycle generally consists of a treatment period followed by a recovery period — for example, chemotherapy → recovery → chemotherapy → recovery. The interval allows healthy cells and the body to recover between treatments.

A cycle is not necessarily one day of treatment. Some chemotherapy regimens involve treatment on one day, while others may involve several treatment days followed by a longer recovery period.

Intravenous chemotherapy. Many breast cancer chemotherapy medicines are administered through a vein. This may be done through a peripheral IV line, a central venous access device or an implanted port. The choice depends on the treatment plan and the patient's veins and treatment duration.

Oral chemotherapy. Some anti-cancer medicines are taken by mouth. Oral treatment still requires careful monitoring because dosage, timing and side effects remain important. The route of administration depends on the specific medicine and treatment plan.

A typical chemotherapy visit may involve medical assessment of current symptoms and side effects, blood tests to decide whether treatment can proceed, medication review, pre-medication to reduce nausea or allergic reactions, the chemotherapy infusion, observation, and discharge if the treatment is provided as day care.

There is no single duration. The time can depend on the number of medicines, infusion speed, pre-medications, observation requirements, hydration, laboratory testing and the type of chemotherapy regimen.

Some treatment visits may take a few hours, while others can take longer. Patients travelling internationally should ask their hospital how long they should expect to remain at the hospital on each treatment day.

Chemotherapy affects cancer cells but can also affect some healthy cells. Possible side effects include fatigue, nausea, vomiting, hair loss, reduced appetite, mouth sores, changes in taste, diarrhoea or constipation, reduced blood-cell counts, increased risk of infection, numbness or tingling in hands and feet, menstrual changes and fertility effects.

Not every patient experiences all of these effects. Side effects vary according to the specific chemotherapy medicines and the individual patient.

Fatigue is common during cancer treatment. It may be caused by chemotherapy, anaemia, poor sleep, reduced food intake, emotional stress, other medicines or the cancer itself. Patients should discuss persistent or severe fatigue with their oncology team because potentially treatable causes may need to be evaluated.

Some chemotherapy medicines cause significant hair loss, while others may cause less. Hair loss can affect scalp hair, eyebrows, eyelashes and other body hair. Hair usually begins to grow back after chemotherapy ends, although the timing varies between patients.

Modern chemotherapy protocols commonly include medicines designed to prevent or reduce chemotherapy-related nausea and vomiting. Patients should take anti-nausea medicines exactly as prescribed. If nausea or vomiting becomes difficult to control, the oncology team should be informed because treatment can often be adjusted.

Chemotherapy can temporarily reduce blood-cell production in the bone marrow. This may affect white blood cells, red blood cells and platelets. A low white blood-cell count can increase infection risk. Low red blood-cell levels can contribute to fatigue. Low platelet levels can increase the risk of bleeding or bruising. For this reason, blood tests are commonly performed during chemotherapy.

Some chemotherapy medicines can cause peripheral neuropathy. Symptoms may include tingling, numbness, burning sensations, sensitivity to touch and weakness. Patients should tell their oncology team if these symptoms develop. Early reporting can help doctors determine whether treatment adjustments are necessary.

Many chemotherapy side effects can be managed or reduced with supportive treatment. Depending on the problem, the oncology team may use anti-nausea medicines, pain medicines, nutritional support, medicines to manage diarrhoea or constipation, growth-factor support in selected situations, treatment for infections or dose adjustments.

Patients should not stop or modify chemotherapy medicines themselves. Any significant side effect should be discussed with the treating oncology team.

There is no single "chemotherapy diet" suitable for everyone. The nutritional goal is generally to maintain adequate calories, protein, fluids, vitamins and minerals. Patients may find it easier to eat smaller, more frequent, protein-rich meals that are easier to tolerate.

If nausea, mouth sores or taste changes make eating difficult, a dietitian or oncology team can provide individualized advice. Patients should also be cautious about supplements and herbal products because some can interact with cancer medicines.

Some patients continue working during chemotherapy, while others need to reduce their workload or take time away from work. It depends on the chemotherapy regimen, side effects, type of work, travel requirements, energy levels, infection risk and overall health. There is no universal rule.

Travel may be possible for some patients, but it needs to be discussed with the treating oncology team. For international patients receiving chemotherapy in India, treatment planning should consider the chemotherapy schedule, blood counts, risk of infection, recovery between cycles, hospital access, emergency care, follow-up appointments and flight timing.

It is generally sensible to avoid planning international travel immediately around a treatment session without discussing the timing with the oncology team.

International patients often need to coordinate chemotherapy over several weeks or months. Before travelling, it can be useful to obtain a preliminary treatment opinion based on the biopsy and histopathology, ER/PR and HER2 results, imaging, previous treatment and medical history. See the international-patient guide.

A possible pathway is: medical records shared → oncology review → additional testing if required → treatment plan → cost estimate → travel to India → chemotherapy → monitoring and follow-up → return home or continue treatment in India. Hospitals in Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad can confirm what to send.

There is no single fixed chemotherapy price. See Chemotherapy Cost in India, Chemotherapy Doctors in India and the breast cancer treatment cost guide.

The total cost can vary according to chemotherapy medicines, drug dosage, number of cycles, treatment regimen, supportive medicines, blood tests, doctor consultations, day-care or hospital charges, port placement where required, management of side effects and other systemic treatments.

A published hospital quotation should therefore specify the actual chemotherapy regimen rather than simply giving a generic "cost per cycle."

The exact inclusions should be confirmed directly with the treating hospital.

Two patients may both be diagnosed with breast cancer but receive very different chemotherapy bills. Costs can differ because one patient may receive a different chemotherapy regimen, a different drug dose, fewer or more cycles, targeted therapy in addition to chemotherapy, immunotherapy in addition to chemotherapy, or more supportive medicines.

Therefore, comparing only the number of cycles does not provide a meaningful cost comparison.

These treatments are different, although they may sometimes be given together. Chemotherapy generally targets rapidly dividing cells. Targeted therapy is designed to act on specific molecular characteristics of cancer — for example, HER2-targeted medicines in appropriate HER2-positive breast cancers.

• Targeted Therapy Doctors in India
• Targeted Therapy Cost in India

Hormone therapy works differently from chemotherapy. For hormone-receptor-positive breast cancer, hormone therapy may be used to interfere with hormonal signals that help certain cancer cells grow. It may be given after surgery, before surgery in selected situations, or for metastatic disease. Chemotherapy may or may not be required in addition.

• Hormone Therapy Cost in India

Immunotherapy works by helping the immune system recognize and attack cancer cells. It is not appropriate for every breast cancer patient. It may be used in selected breast cancer settings, including certain triple-negative breast cancers.

• Immunotherapy Doctors in India
• Immunotherapy Cost in India

Finishing chemotherapy does not necessarily mean that breast cancer treatment is complete. Depending on the patient's treatment plan, the next steps may include surgery, radiation therapy, hormone therapy, targeted therapy, immunotherapy, follow-up imaging, blood tests and long-term surveillance.

A patient with locally advanced HER2-positive breast cancer may receive systemic treatment before surgery. A simplified pathway could be: diagnosis → biopsy → HER2 testing → neoadjuvant systemic treatment → surgery → radiation/systemic treatment. The actual medicines and sequence depend on the patient's individual diagnosis.

A patient with an early-stage breast cancer for whom chemotherapy is recommended may have: diagnosis → lumpectomy → pathology → chemotherapy → radiation → hormone therapy. This is an example rather than a standard sequence for every patient.

For metastatic breast cancer, systemic therapy is central to treatment. Chemotherapy may be used depending on cancer subtype, previous treatment, rate of disease progression, symptoms, organ involvement, hormone-receptor status, HER2 status and other biomarkers.

For some metastatic breast cancers, hormone therapy or targeted therapy may be preferred over chemotherapy depending on the tumour biology. The treatment objective is generally disease control and management rather than simply removing the original breast tumour.

Patients travelling to India for chemotherapy should ideally bring copies of all previous medical records: biopsy and histopathology, ER, PR, HER2 and other biomarker reports; mammography, ultrasound, MRI, CT, PET-CT and bone scans where applicable; surgery reports, chemotherapy records, radiation records, previous medication lists and discharge summaries; plus allergies, other medical conditions, current medicines and previous treatment side effects.

If possible, pathology slides or tissue blocks may also be requested for review.

Patients receiving chemotherapy should have clear instructions from their treatment team about symptoms that require urgent assessment. Depending on the chemotherapy regimen, these may include fever, chills, difficulty breathing, severe vomiting, persistent diarrhoea, significant bleeding, severe weakness, new confusion and signs of infection.

The exact emergency instructions should be provided by the treating oncology team because risks vary between chemotherapy regimens.

No. The need for chemotherapy depends on stage, tumour biology, lymph-node status and other clinical factors.

There is no universal number. The number of cycles depends on the specific chemotherapy regimen and treatment objective.

Yes. This is called neoadjuvant chemotherapy and is used in selected patients.

Yes. This is called adjuvant chemotherapy and may be recommended depending on the patient's risk and tumour characteristics.

It varies according to the medicines, infusion schedule, pre-medications and monitoring requirements. Some treatments take a few hours, while others can take longer.

Some chemotherapy medicines cause significant hair loss, while others may cause less. The oncology team can explain the expected effects of the specific regimen.

It can. Anti-nausea medicines are commonly used to prevent or control chemotherapy-related nausea and vomiting.

Some chemotherapy medicines can affect fertility. Patients who may wish to have children in the future should discuss fertility preservation with their oncology team before treatment begins.

Some patients continue working, while others reduce their workload or take time off. The decision depends on the treatment and how the patient feels.

Yes. International patients can seek chemotherapy treatment in India. Their medical records can be reviewed before travel to help develop a treatment plan.

There is no single fixed price. Cost depends on the medicines, dosage, number of cycles, supportive treatment, investigations and hospital charges.

Yes. In selected breast cancers, particularly certain HER2-positive cancers, chemotherapy and targeted therapy may be used together.

Yes, in selected treatment settings. Whether this is appropriate depends on the cancer subtype, stage and treatment plan.

Chemotherapy is an important treatment option for some breast cancer patients, but it is not automatically required for everyone. The decision depends on the complete cancer profile, including stage, tumour size, lymph-node involvement, ER and PR status, HER2 status, tumour grade, breast cancer subtype, previous treatment and overall health.

Chemotherapy can be given before surgery, after surgery or for metastatic breast cancer. For international patients considering treatment in India, the most useful first step is to have the complete pathology and medical records reviewed by a medical oncology team.

• Breast Cancer Treatment in India
• Chemotherapy Doctors in India
• Chemotherapy Cost in India
• Medical Oncology Doctors in India
• Medical Oncology Hospitals in India
• Radiation Therapy for Breast Cancer
• Hormone Therapy for Breast Cancer
• HER2-Positive Breast Cancer Treatment
• Breast Reconstruction After Mastectomy
• Breast Cancer Treatment by Stage
• Treatment for international patients